Rezolute's Phase 3 sunRIZE Study for Ersodetug Fails to Meet Primary and Secondary Endpoints Despite Analyst Backing
Rezolute Inc. (NASDAQ:RZLT) is one of the best biotech penny stocks to buy according to analysts.
Rezolute Inc. (RZLT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 9,445,039 | $49,114,203 | +3% | 0.43% |
| 2. | Opaleye Management James A. Silverman | 6,300,000 | $32,760,000 | 2.97% | |
| 3. | Balyasny Asset Management Dmitry Balyasny | 4,662,039 | $24,242,603 | -8% | 0.03% |
| 4. | Siren L.L.C. Raymond Debbane | 3,328,287 | $17,307,092 | 0.35% | |
| 5. | D E Shaw D. E. Shaw | 1,839,357 | $9,564,656 | +5% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.85 | 10,000 | $28,500.00 | 414,462 | 2026-03-30 | Filing | |
| $1.69 | 5,650 | $9,548.50 | 119,675 | 2025-12-16 | Filing | |
| $1.70 | 28,000 | $47,600.00 | 308,352 | 2025-12-16 | Filing | |
| $1.79 | 2,500 | $4,475.00 | 7,000 | 2025-12-15 | Filing | |
| $1.79 | 2,500 | $4,462.50 | 7,000 | 2025-12-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 842,949 | $0.00 | 0 | 2015-02-09 | Filing | |
| $0.08 | 893,750 | $75,075.00 | 0 | 2012-09-04 | Filing | |
| $0.08 | 10,000 | $840.00 | 0 | 2012-09-04 | Filing | |
| $0.08 | 893,750 | $75,075.00 | 0 | 2012-09-04 | Filing | |
| $0.08 | 893,750 | $75,075.00 | 0 | 2012-09-04 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12,990,659 | $67,551,427 | 0.1% | |
| 2. | 7,718,291 | $40,135,113 | 0% | |
| 3. | 3,835,827 | $19,946,300 | 0% | |
| 4. | 2,561,654 | $13,320,601 | 0.05% | |
| 5. | 2,459,308 | $12,788,402 | 0.01% |
News See All
10 Best Biotech Penny Stocks to Buy According to Analysts
On December 24, Jared Holz of Mizuho joined 'Power Lunch' on CNBC to talk about how to play biotech moving into 2026.
Is Rezolute Inc. (RZLT) One of the Top Long-Term Biotechnology Stocks to Buy
Rezolute Inc. (NASDAQ:RZLT) is one of the top long-term biotechnology stocks to buy. Wedbush analyst Yun Zhong reaffirmed a Buy rating on Rezolute Inc.
Top 8 Long-Term Biotechnology Stocks to Buy
In this article, we will examine the Top 8 Long-Term Biotechnology Stocks to Buy. Momentum in biotechnology stocks is accelerating after years of underperformance.
13 Best Multibagger Stocks to Invest in Now
In this article, we identify the 13 Best Multibagger Stocks to invest in now.
10 Best Multibagger Stocks To Buy Heading into 2025
In this article, we discuss the 10 best multi-bagger stocks to buy heading into 2025 along with the market conditions post-election.
Insiders are Piling into These 5 Healthcare Stocks in 2024
This article presents an overview of Insiders are Piling into These 5 Healthcare Stocks in 2024.
Insiders Are Buying These 5 Penny Stocks
This article presents an overview of Insiders Are Buying These 5 Penny Stocks. For a detailed overview of the 15 such stocks read our article, Insiders Are Buying These 11 Penny Stocks. 5.
Hedge Fund Resource Center